Is Replimune Group, Inc. (REPL) a Buy, Sell, or Hold?
Replimune Group, Inc.
NASDAQ:REPL
$9.68 USD
-$0.19 (-1.93%)
- Volume
- 1.58M
- Average Volume
- 6.37M
- Market Capitalization
- $812.59M
- P/E Ratio
- -2.86
- Dividend Yield
- 0.00%
- Price Target
- $14.00
- Year High
- $13.24
- Year Low
- $1.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.79
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
25
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
15
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 199.45K
REPL Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
REPL Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Sarchi Christopher | officer: Chief Commercial Officer | 2026-06-01 | S-Sale | 9.24 | 2026-06-03 |
| Xynos Konstantinos | officer: Chief Medical Officer | 2026-05-18 | S-Sale | 5.08 | 2026-05-20 |
| Schwendenman Andrew | officer: Chief Accounting Officer | 2026-05-18 | S-Sale | 5.08 | 2026-05-20 |
| Sarchi Christopher | officer: Chief Commercial Officer | 2026-05-18 | S-Sale | 5.08 | 2026-05-20 |
| Astley-Sparke Philip | director | 2026-05-18 | S-Sale | 5.08 | 2026-05-20 |
| Patel Sushil | director, officer: Chief Executive Officer | 2026-05-18 | S-Sale | 5.08 | 2026-05-20 |
| Hill Emily Luisa | officer: Chief Financial Officer | 2026-05-18 | S-Sale | 5.08 | 2026-05-20 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| Sarchi Christopher | officer: Chief Commercial Officer | 2026-04-01 | A-Award | 0 | 2026-04-07 |
| Sarchi Christopher | officer: Chief Commercial Officer | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| Astley-Sparke Philip | director | 2026-04-01 | A-Award | 0 | 2026-04-07 |
| Astley-Sparke Philip | director | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| Oliger Christy J. | director | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| Xynos Konstantinos | officer: Chief Medical Officer | 2026-04-01 | A-Award | 0 | 2026-04-07 |
| Xynos Konstantinos | officer: Chief Medical Officer | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| Balachandran Madhavan | director | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| Schwendenman Andrew | officer: Chief Accounting Officer | 2026-04-01 | A-Award | 0 | 2026-04-07 |
| Schwendenman Andrew | officer: Chief Accounting Officer | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| Patel Sushil | director, officer: Chief Executive Officer | 2026-04-01 | A-Award | 0 | 2026-04-07 |
| Patel Sushil | director, officer: Chief Executive Officer | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| Dhingra Kapil | director | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| Pucci Paolo | director | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| SLATTERY JOSEPH P | director | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| Peeples-Dyer Veleka | director | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| Hill Emily Luisa | officer: Chief Financial Officer | 2026-04-01 | A-Award | 0 | 2026-04-07 |
| Hill Emily Luisa | officer: Chief Financial Officer | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| Weinand Dieter | director | 2026-04-01 | A-Award | 7.61 | 2026-04-07 |
| Sarchi Christopher | officer: Chief Commercial Officer | 2026-04-02 | S-Sale | 8.01 | 2026-04-06 |
| Astley-Sparke Philip | director | 2026-02-18 | G-Gift | 0 | 2026-02-20 |
| Patel Sushil | director, officer: Chief Executive Officer | 2025-12-19 | A-Award | 0 | 2025-12-19 |
| Xynos Konstantinos | officer: Chief Medical Officer | 2025-12-19 | A-Award | 0 | 2025-12-19 |
| Hill Emily Luisa | officer: Chief Financial Officer | 2025-12-19 | A-Award | 0 | 2025-12-19 |
| Sarchi Christopher | officer: Chief Commercial Officer | 2025-12-19 | A-Award | 0 | 2025-12-19 |
| Schwendenman Andrew | officer: Chief Accounting Officer | 2025-12-19 | A-Award | 0 | 2025-12-19 |
| Dhingra Kapil | director | 2025-12-09 | M-Exempt | 1.75 | 2025-12-11 |
| Dhingra Kapil | director | 2025-12-09 | M-Exempt | 1.75 | 2025-12-11 |
| Dhingra Kapil | director | 2025-12-09 | S-Sale | 10.4 | 2025-12-11 |
| Patel Sushil | director, officer: Chief Executive Officer | 2025-12-02 | S-Sale | 11.13 | 2025-12-04 |
| Sarchi Christopher | officer: Chief Commercial Officer | 2025-11-17 | S-Sale | 9.1 | 2025-11-19 |
| Xynos Konstantinos | officer: Chief Medical Officer | 2025-11-17 | S-Sale | 9.1 | 2025-11-19 |
| Hill Emily Luisa | officer: Chief Financial Officer | 2025-08-15 | S-Sale | 5.37 | 2025-08-19 |
| Astley-Sparke Philip | director | 2025-05-20 | S-Sale | 8.06 | 2025-05-22 |
| Xynos Konstantinos | officer: Chief Medical Officer | 2025-05-20 | S-Sale | 8.06 | 2025-05-22 |
| Schwendenman Andrew | officer: Chief Accounting Officer | 2025-05-20 | S-Sale | 8.05 | 2025-05-22 |
| Patel Sushil | director, officer: Chief Executive Officer | 2025-05-20 | S-Sale | 8.06 | 2025-05-22 |
| Hill Emily Luisa | officer: Chief Financial Officer | 2025-05-20 | S-Sale | 8.05 | 2025-05-22 |
| Sarchi Christopher | officer: Chief Commercial Officer | 2025-05-20 | S-Sale | 8.05 | 2025-05-22 |
| Peeples-Dyer Veleka | director | 2025-04-01 | A-Award | 8.4 | 2025-04-03 |
| Patel Sushil | director, officer: Chief Executive Officer | 2025-04-01 | A-Award | 0 | 2025-04-03 |
| Patel Sushil | director, officer: Chief Executive Officer | 2025-04-01 | A-Award | 8.4 | 2025-04-03 |
| Pucci Paolo | director | 2025-04-01 | A-Award | 8.4 | 2025-04-03 |
| Balachandran Madhavan | director | 2025-04-01 | A-Award | 8.4 | 2025-04-03 |
| Xynos Konstantinos | officer: Chief Medical Officer | 2025-04-01 | A-Award | 0 | 2025-04-03 |
| Xynos Konstantinos | officer: Chief Medical Officer | 2025-04-01 | A-Award | 8.4 | 2025-04-03 |
| Dhingra Kapil | director | 2025-04-01 | A-Award | 8.4 | 2025-04-03 |
| SLATTERY JOSEPH P | director | 2025-04-01 | A-Award | 8.4 | 2025-04-03 |
| Hill Emily Luisa | officer: Chief Financial Officer | 2025-04-01 | A-Award | 0 | 2025-04-03 |
| Hill Emily Luisa | officer: Chief Financial Officer | 2025-04-01 | A-Award | 8.4 | 2025-04-03 |
| Weinand Dieter | director | 2025-04-01 | A-Award | 8.4 | 2025-04-03 |
| Sarchi Christopher | officer: Chief Commercial Officer | 2025-04-01 | A-Award | 0 | 2025-04-03 |
| Sarchi Christopher | officer: Chief Commercial Officer | 2025-04-01 | A-Award | 8.4 | 2025-04-03 |
| Oliger Christy J. | director | 2025-04-01 | A-Award | 8.4 | 2025-04-03 |
| Schwendenman Andrew | officer: Chief Accounting Officer | 2025-04-01 | A-Award | 0 | 2025-04-03 |
| Schwendenman Andrew | officer: Chief Accounting Officer | 2025-04-01 | A-Award | 8.4 | 2025-04-03 |
| GOLLER MICHAEL | 2025-03-05 | 0 | 2025-03-07 | ||
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2025-03-05 | A-Award | 12.29 | 2025-03-07 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2025-03-05 | 0 | 2025-03-07 | |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2025-03-05 | 0 | 2025-03-07 | |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2025-03-05 | 0 | 2025-03-07 | |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2025-03-05 | 0 | 2025-03-07 | |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2025-03-05 | 0 | 2025-03-07 | |
| Patel Sushil | director, officer: Chief Executive Officer | 2024-12-16 | S-Sale | 12.42 | 2024-12-18 |
| Xynos Konstantinos | officer: Chief Medical Officer | 2024-11-18 | S-Sale | 10.78 | 2024-11-20 |
| Sarchi Christopher | officer: Chief Commercial Officer | 2024-11-18 | S-Sale | 10.78 | 2024-11-20 |
| Balachandran Madhavan | director | 2024-09-04 | A-Award | 10.44 | 2024-09-05 |
| Balachandran Madhavan | director: | 2024-09-04 | 0 | 2024-09-05 | |
| Astley-Sparke Philip | director, officer: Executive Chairman | 2024-08-30 | G-Gift | 0 | 2024-08-30 |
| Hill Emily Luisa | officer: Chief Financial Officer | 2024-08-16 | S-Sale | 10.18 | 2024-08-19 |
| Xynos Konstantinos | officer: Chief Medical Officer | 2024-06-07 | S-Sale | 7.5 | 2024-06-10 |
| Sarchi Christopher | officer: Chief Commercial Officer | 2024-05-16 | S-Sale | 6.47 | 2024-05-20 |
| Schwendenman Andrew | officer: Chief Accounting Officer | 2024-05-16 | S-Sale | 6.47 | 2024-05-20 |
| Love Colin | officer: Chief Operating Officer | 2024-05-16 | S-Sale | 6.47 | 2024-05-20 |
| Astley-Sparke Philip | director, officer: Executive Chairman | 2024-05-16 | S-Sale | 6.47 | 2024-05-20 |
| Coffin Robert | director | 2024-05-16 | S-Sale | 6.47 | 2024-05-20 |
| Patel Sushil | director, officer: Chief Executive Officer | 2024-05-16 | S-Sale | 6.47 | 2024-05-20 |
| Xynos Konstantinos | officer: Chief Medical Officer | 2024-05-16 | S-Sale | 6.47 | 2024-05-20 |
| Peeples-Dyer Veleka | director | 2024-04-01 | A-Award | 7.73 | 2024-04-03 |
| Patel Sushil | director, officer: Chief Executive Officer | 2024-04-01 | A-Award | 7.73 | 2024-04-03 |
| Patel Sushil | director, officer: Chief Executive Officer | 2024-04-01 | A-Award | 0 | 2024-04-03 |
| Pucci Paolo | director | 2024-04-01 | A-Award | 7.73 | 2024-04-03 |
| Xynos Konstantinos | officer: Chief Medical Officer | 2024-04-01 | A-Award | 0 | 2024-04-03 |
| Xynos Konstantinos | officer: Chief Medical Officer | 2024-04-01 | A-Award | 7.73 | 2024-04-03 |
| Dhingra Kapil | director | 2024-04-01 | A-Award | 7.73 | 2024-04-03 |
| Hill Emily Luisa | officer: Chief Financial Officer | 2024-04-01 | A-Award | 0 | 2024-04-03 |
| Hill Emily Luisa | officer: Chief Financial Officer | 2024-04-01 | A-Award | 7.73 | 2024-04-03 |
| Sarchi Christopher | officer: Chief Commercial Officer | 2024-04-01 | A-Award | 0 | 2024-04-03 |
| Sarchi Christopher | officer: Chief Commercial Officer | 2024-04-01 | A-Award | 7.73 | 2024-04-03 |
| SLATTERY JOSEPH P | director | 2024-04-01 | A-Award | 7.73 | 2024-04-03 |
| Weinand Dieter | director | 2024-04-01 | A-Award | 7.73 | 2024-04-03 |
| Oliger Christy J. | director | 2024-04-01 | A-Award | 7.73 | 2024-04-03 |